Background: Tissue oxygenation is a strong predictor of surgical site infection. Improving tissue oxygenation should thus reduce wound infection risk. Supplemental inspired oxygen can improve tissue oxygenation, but whether it reduces infection risk remains controversial. Low-dose dexamethasone is often given to reduce the risk of postoperative nausea and vomiting, but steroid-induced immunosuppression can increase infection risk. We therefore tested the hypotheses that supplemental perioperative oxygen reduces infection risk and that dexamethasone increases it. Methods: Using a factorial design, patients having colorectal resections expected to last ≥2 h were randomly assigned to 30% (n=270) or 80% (n=285) inspired oxygen during and for 1 h after surgery, and to 4 mg intraoperative dexamethasone (n=283) or placebo (n=272). Physicians blinded to group assignments evaluated wounds postoperatively, using US Centers for Disease Control criteria. Results: Subject and surgical characteristics were similar among study groups. Surgical site infection incidence was similar among groups: 30% oxygen 15.6%, 80% oxygen 15.8% (P=1.00); dexamethasone 15.9%, placebo 15.4%, (P=0.91). Conclusions: Supplemental oxygen did not reduce surgical site infection risk. The preponderance of clinical evidence suggests that administration of 80% supplemental inspired oxygen does not reduce infection risk. We did not observe an increased risk of surgical site infection with the use of a single low dose of dexamethasone, indicating that it can be used for nausea and vomiting prophylaxis without promoting wound infections. Clinical trial registration: ClinicalTrials.gov number: NCT00273377.
Tissue oxygenation, reflecting local perfusion and arterial oxygen partial pressure (Pa O 2 ), is enhanced by cardiac output, 13 pain control, 14 supplemental fluid, 15 management of carbon dioxide (CO 2 ), 16 17 and epidural anaesthesia. 18 In the presence of adequate tissue perfusion, supplemental oxygen increases wound tissue oxygen. 2 However, only one study has measured wound tissue oxygen tension and showed that when this is increased by higher supplemental oxygen levels, SSI risk was reduced. 2 This and another trial in colorectal surgery patients showed that SSI risk was roughly halved when patients were given 80% inspired oxygen rather than 30% 2 19 ; however, other trials performed in abdominal surgery patients (colorectal, caesarean section) failed to demonstrate any benefit. [20] [21] [22] [23] [24] Although the design, patient groups, and inclusion criteria differ somewhat, protocol differences seem insufficient to explain such divergent results. Additional data are thus clearly needed. We therefore tested the hypothesis that supplemental oxygen (80% vs 30%) reduces SSI risk. Steroids are immunosuppressive and can therefore reduce resistance to bacterial contamination-especially when given during the initial 'decisive period' when the immune system either successfully contains the inevitable wound contamination that accompanies even clean surgery, or fails, leading to clinical infection. Consistent with this concept, chronic steroid use augments wound infection risk. 25 26 However, the most common perioperative use of steroids is as a single low dose for prevention of postoperative nausea and vomiting (PONV). 27 A retrospective analysis found no statistically significant increase in SSI in patients given 4-8 mg of dexamethasone intraoperatively. 28 A subanalysis of the PROXI Trial concluded that perioperative dexamethasone neither promoted surgical wound complications (composite of SSI, anastomotic leak, wound dehiscence, burst abdomen) nor increased 30-day mortality. 29 In contrast, a case-control analysis reported that low-dose dexamethasone increases infection risk, 30 while another case-control study did not find an increased risk of SSI with a single dose of dexamethasone (4-8 mg) in gynaecological patients. 31 Finally, a retrospective study did not identify an increased risk of wound complications (cellulitis, superficial SSI, wound separation, and fascial dehiscence) when 4-12 mg of dexamethasone was used for PONV management in patients having endometrial cancer surgery. 32 There remains a paucity of data from patients in whom dexamethasone administration was randomly assigned and wound infections carefully evaluated. Using factorial randomisation, we tested the additional hypothesis that a single 4-mg intraoperative dose of dexamethasone increases SSI risk.
Methods
With institutional review board approval from each participating centre and written consent from participating patients, we enrolled adults ≤80 or 80% inspired oxygen and to 4 mg dexamethasone or placebo. The sample size for the overall trial was based on the hypercapnia intervention. As described previously, the Executive Committee stopped the overall trial after 1215 patients were enrolled, of whom 586 were randomized to supplemental oxygen and dexamethasone (Fig. 1 ). In the main hypercapnia and SSI trial, patients were randomly assigned to intraoperative normocapnia [end tidal CO 2 (ET CO 2 )≈35 mm Hg; n=623] or hypercapnia (ET CO 2 ≈50 mm Hg; n=592); similarly, 30-day SSI was assessed as the main study outcome.
Protocol
Most patients were given electrolyte bowel preparation without antibiotics the night before surgery. Per surgical routine, cefuroxime (1.5 g i.v.) and metronidazole (0.5 g i.v.), cefotetan (2 g i.v.), or ertapenem (1 g i.v.) were given during anaesthetic induction. Propofol (2-4 mg kg −1 ) and rocuronium (0.6 mg kg −1 ) or vecuronium (0.1 mg kg −1 ) were used for induction; subsequently anaesthesia was maintained with desflurane or sevoflurane, fentanyl, and muscle relaxants as clinically required. Combined epidural and general anaesthesia were permitted, as was postoperative epidural analgesia. After induction of anaesthesia, 586 subjects were assigned in a factorial manner to intraoperative F O 2 of 0.30 or 0.80, to no dexamethasone or 4 mg dexamethasone, and to normocapnia or hypercapnia. Independent investigators prepared dexamethasone and normal saline placebo solution in unmarked 2 ml syringes, which were provided to the clinical team. All assignments were based on computer-generated randomisations that were kept in opaque, sealed, sequentially numbered envelopes until shortly before surgery.
Subjects were assigned to 30% or 80% intraoperative inspired oxygen after induction of anaesthesia; the balance gas was always nitrogen. They were simultaneously randomized to receive 4 mg i.v. dexamethasone or placebo within 15 min of anaesthetic induction. Oxygen administration was increased as necessary to maintain pulse oximeter saturation (Sp O 2 ) ≥95%. All subjects were given 100% oxygen during anaesthesia induction and emergence. The designated oxygen concentration was then continued for the first hour of recovery with a nonrebreathing mask (Hi-Ox, Viasys Healthcare, Wheeling, IL, USA) with a fresh-gas flow rate of 1 litre min −1 (30% group) or 5 litres min −1 (80% group). This mask system accurately provides the desired inspired oxygen concentration at the designated fresh-gas flows. 33 Subsequently oxygen was titrated to room air if Sp O 2 was ≥92%. Volatile anaesthetic administration was adjusted to maintain a mean arterial pressure (MAP) of ∼90% of the pre-induction value. Intraoperative crystalloids were generally given at a rate of 6-10 ml kg −1 h −1 , based on actual body weight, even if obese, Editor's key points
• Conflicting reports have led to controversy regarding the roles of high inspired oxygen fraction and low doses of dexamethasone in the rate of surgical site infection.
• In a prospective factorial design study, subjects undergoing colorectal surgery were randomized to high or low inspired oxygen, with or without dexamethasone.
• There was no effect of high inspired oxygen or anti-emetic doses of dexamethasone on surgical site infection rate. ; however, variations based on clinical judgement were permitted. The target minimum haematocrit (HCT) was determined before randomisation based on the age and cardiovascular status: target HCT was 26% in subjects <65 yr old having no significant cardiovascular disease and 28% in subjects ≥65 yr old or having cardiovascular disease. Significant cardiovascular disease was defined as a history of myocardial infarction or peripheral vascular disease. HCT was maintained at ≥30% in subjects having both significant cardiovascular disease and age ≥65 yr. Intraoperative core temperature was maintained near 36°C by forced-air warmers and fluid warmers as per the attending anaesthesiologists' requests throughout the intraoperative period.
Anaesthesiologists were not blinded to group assignments, but flow meters and gas monitors were shielded to prevent surgeons from determining randomisation. After giving the handoff report to the post-anaesthesia care unit, the anaesthesia record was sealed in an envelope as part of the blinding process until discharge (except at the University of Vienna and the Cleveland Clinic, which each used electronic records). Postoperative pain relief was maintained by patient-controlled i.v. morphine or hydromorphone analgesia, or by epidural analgesia.
Attending surgeons made hospital discharge decisions. Discharge timing was based on routine surgical considerations, including return of bowel function, control of infections (if any), adequate healing of the incision, and overall recovery during the postoperative period.
Measurements
Arterial blood sampling for gas analysis was not required by protocol, but values were recorded when samples were obtained for clinical reasons. If there was more than one arterial blood gas sample, the average of the assessments was reported. Core temperatures were measured continuously from the oesophagus or nasopharynx. Factors potentially influencing infection risk were recorded, including patient co-morbidity, laboratory values, and anaesthetic and surgical management. Patients were asked to rate their pain on a 10 cm visual analogue scale (VAS) during the first hour of recovery and on the first postoperative morning. In the recovery period, pain scores were recorded at 30 min intervals. On the first postoperative morning, subjects were asked to provide a single VAS that summarised their pain experience since leaving the recovery unit. PONV management was not standardized in the protocol, but prophylactic administration of ondansetron as a single preventive agent for all patients was recommended. Dexamethasone as rescue antiemetic was forbidden by the protocol.
Infection risk was evaluated with the System from the Efficacy of Nosocomial Infection Control (SENIC) of the Centers for 
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Withdrawn n=0 The first 629 subjects were assigned to normocapnia or hypercapnia at an FO Disease Control and Prevention (CDC), which assigns 1 point for each of the following factors: three or more underlying diagnoses at discharge, surgery that lasts ≥2 h, abdominal site of surgery, and the presence of a contaminated or infected wound. 35 As in previous studies, 1-3 we modified the system by using the number of diagnoses at admission rather than at discharge. Although the SENIC score was established well before laparoscopic surgery became common, we designated subjects having laparoscopic-assisted colectomies as having an abdominal surgical site. Infection risk was also evaluated with the National Nosocomial Infection Surveillance System (NNISS), which predicts risk on the basis of type of surgery, rating of physical status on a scale developed by the ASA, and duration of surgery.
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170 (11) 171 (11) 170 (11) 172 ( ), mean () 27 (7) 27 (6) 28 (7) 27 (6) Age (yr), mean () 51 (17) 54 (16) 52 (16) 38 This is an established and validated system for quantifying surgical wound infections and evaluating wound healing. The score is derived from the weighted sum of points assigned for the following factors: duration of antibiotic administration, drainage of pus under local anaesthesia, debridement of the wound under general anaesthesia, serous discharge, erythema, purulent exudate, separation of deep tissues, isolation of bacteria from discharge, and hospitalisation exceeding 14 days. Wounds were evaluated daily throughout hospitalisation by an investigator blinded to treatment. Subsequently subjects were called on the 15th and 30th day and a scripted interview was used to enquire about SSI. When answers suggested that infection was likely, efforts were made to obtain relevant records. An investigator blinded to treatment adjudicated infections and complications using all available data.
Data analysis
Our primary outcome was the incidence of SSI within 30 days of surgery. Secondary outcomes included wound-healing scores, return of bowel function, and duration of hospitalisation. Multivariable logistic regression analysis was used to assess the marginal contributions of inspired oxygen and dexamethasone to wound infection risk.
As a secondary analysis, we used multiple regression to assess the fractional contribution of potentially related factors, including morphometric characteristics, age, SENIC and NNISS scores, history of current or previous smoking, diabetes mellitus, glucose concentration, CO 2 partial pressure, allogeneic transfusion, postoperative pain, and duration of surgery. Factors contributing <10% to the model's overall ability to predict wound infections were sequentially eliminated until only factors contributing at P ≤ 0.05 were retained.
Results
We enrolled 586 subjects in five centres (Bern, 29; Cleveland, 295; Dublin, 29; Louisville, 102; Vienna, 131); data from 555 subjects were analysable (Fig. 1) . Clinical characteristics, diagnoses, surgical procedures, duration of surgery, haemodynamic values, and anaesthetic management were generally similar in subjects randomized to each intervention. However, an open surgical approach was used slightly more often in subjects assigned to 80% rather than 30% inspired oxygen, and subjects assigned to dexamethasone were given slightly more fentanyl and volatile anaesthesia (Table 1) . Prophylactic antibiotics were given a mean of 36 min ( 40) before skin incision.
Overall SSI rates in the centres ranged from 8 to 20% (P =0.098). SSI incidence was similar in each study group: 30% oxygen 15.6, 80% oxygen 15.8% (P=1.00); dexamethasone 15.9%, placebo 15.4% (P=0.91). Both the oxygen and dexamethasone interventions easily crossed predefined futility boundaries.
There were more deep wound infections in subjects assigned to 80% oxygen (7%) than in those assigned to 30% oxygen (3%; P=0.033). The duration of hospitalisation was about 1 day longer in the 80% oxygen group (Table 2) . There was no evidence of an interaction either between oxygen and dexamethasone or between either intervention and hypercapnia. There were also no significant differences between treatment groups in ASEPSIS scores, major complications, or mortality.
The average inspired oxygen fraction in subjects assigned to a target of 30% was 39% ( 8) and resulted in a Pa O2 of 119 mm Hg ( 54) (n=120). The average inspired oxygen fraction in subjects assigned to a target of 80% was 78% ( 6) and resulted in an overall Pa O 2 of 237 mm Hg ( 120) (n=121; at Cleveland Clinic Alumni Library on October 9, 2015 http://bja.oxfordjournals.org/
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The only independent factors associated with the SSI rate were body mass index (BMI) and history of smoking (including both current and former smokers). Surgical approach (laparoscopic-assisted or open), ASA physical status, and SENIC scores did not show any significant relationship with SSI incidence. Overall mortality was too low to be considered within any comparison, as expected, since the study was not powered for this outcome (Table 3) .
Major complications included readmission (49), fluid electrolyte imbalance (17) , anastomotic leak (12), ileus (6), wound dehiscence (6), pneumonia (6), sepsis (5), and acute renal failure (5). Stress-dose steroids were given to only 33 subjects, of whom 18% developed, wound infections.
Discussion
Oxidative killing by neutrophils is the primary defence against bacterial infection.
6 Supplemental oxygen therapy can increase the formation of reactive oxygen species, thus improving the oxidative killing. 5 6 Furthermore, observational results indicate that tissue oxygenation is an important predictor of experimental 11 and clinical 9 12 infections.
The initial randomized evidence came from a trial of colon resection in which 500 subjects were assigned to 30% or 80% inspired oxygen (7.9 to 14.5 kPa); the latter increased tissue oxygenation from 59 to 109 mm Hg and halved the infection risk. 2 This result was confirmed in a trial of 300 colon resection patients.
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A subsequent study reported that supplemental oxygen increased wound infection risk, 21 while Meyhoff and colleagues 20 found that infection risk was comparable in 1400 general surgical patients randomized to 30 or 80% inspired oxygen. In the latter study, only 633 patients had colorectal surgery, and the SSI rates were 25% for the 30% oxygen group and 24% for the 80% group (P=0.68); both values far exceeded our observed incidence of 16% and also exceeded the incidence described in most previous reports. In distinct contrast to the initial approximately 800 subjects we studied in two trials, our current results in 555 subjects demonstrate no benefit of randomisation to 80% inspired oxygen, which is consistent with the findings of Meyhoff and colleagues. 20 The effects of 80% inspired oxygen on surgical outcomes were tested in two recent trials in patients undergoing caesarean section surgery. In a randomized, double-blind trial, patients having caesarean delivery (n=831) were randomized to 30 or 80% inspired oxygen intraoperatively and during the first postoperative hour. 22 Another study assigned patients having caesarean deliveries (n=179) to 30 or 80% inspired oxygen intraoperatively and for the first two postoperative hours. 23 Neither study identified a difference in infection rates. A study of the role of supplemental inspired oxygen in abdominal, gynaecologic, and breast surgery patients (n=434) or 30-day SSI also did not identify a statistically significant difference in infection risk in the two oxygen groups. 24 Factors likely to influence tissue oxygenation differed among trials (Table 4 gave their patients much less fluid than in the other studies, which might have compromised peripheral perfusion and oxygen delivery even in patients given supplemental oxygen. It is noteworthy that only one of the many trials (Greif and colleagues 2 ) demonstrated that increased inspired oxygen led to the desired effect (increased wound oxygen) and that this study demonstrated a benefit. While we cannot be certain that wound oxygen tension was not increased in the other negative trials, we also cannot be certain that it was, because in most cases wound tissue oxygen tension was not directly measured. The trial by Belda and colleagues 19 that most closely replicated the conditions of the Greif and colleagues 2 trial also demonstrated a positive effect of high inspired oxygen. The protocol for our study specified application of the designated oxygen concentration only for the first postoperative hour, which was 1 h less than most previous studies. In our study, subjects receiving F O 2 =0.8 had a slightly prolonged length of stay, delayed recovery of bowel function, and an increased incidence of deep infection compared with those randomized to F O 2 =0.3. This is difficult to explain, given the randomisation process, and could represent chance findings. It is also possible that higher supplemental oxygen has a detrimental effect on SSI rate, as suggested by the relatively small study of Pryor and colleagues, 21 contributing to impaired bowel recovery and lengthening hospital stay. However, the balance of evidence suggests a neutral effect of higher supplemental oxygen on SSI. Global and tissue oxygen delivery thus might also have differed among the studies. Available studies of supplemental oxygen also differ in terms of inclusion and exclusion criteria and overall design. For example, Meyhoff and colleagues 20 included urgent and emergent cases, and possibly as a result, they report greater infection and mortality rates than other trials. Pain scores also varied among participating centres, which is not unexpected, because of variation in cultural perception of pain and clinical practice to deliver analgesia. While pain affects tissue oxygen tension, 14 there were no significant differences in pain scores between groups, therefore we think it is unlikely that this factor would have confounded our findings.
Arterial blood analyses were obtained in ∼43% of subjects. Arterial oxygen partial pressures were lower than in previous (Table 4 ). There were two important protocol differences compared with previous studies. First, blood was generally sampled late in surgery when atelectasis and other factors have often reduced gas exchange efficiency. Second, blood gas analysis was conducted for clinical reasons rather than being required by protocol, thus it is likely that samples were obtained in patients with baseline risk for pulmonary problems or apparent intraoperative difficulties. Thus the duration of surgery was longer in the subjects in whom blood gas analysis was performed [4.0 h ( 1.7) vs 3.1 (1.4)]. It therefore seems likely that arterial oxygenation was greater in the population as a whole than in subjects selected for blood gas analysis. Nonetheless, despite subjects with lower Pa O2 having higher SSI rates up to about 100 mm Hg, it is intriguing that higher supplemental oxygen did not reduce SSI when Pa O2 exceeded this level. This may be partly attributable to impaired lung function, such as atelectasis, preventing higher oxygen delivery to wound tissue. Infection rates were double in subjects with relative hypoxaemia. Given that these subjects were on at least 30% oxygen, this suggests that they had poor pulmonary function. These subjects would have contributed substantially to the observed infection rate, given that the rate in the subjects with higher Pa O 2 was below average. A lack of increase in Pa O 2 in response to F O 2 =0.8, attributable to impaired pulmonary function, would be another explanation for why the intervention might not have increased wound tissue oxygen partial pressure.
Obesity reduces tissue oxygenation, and it is also well established that obese patients experience more perioperative complications and increased SSI rates. 42 Our results extend previous findings by presenting a clear relationship between BMI and SSI. However, obese patients might have received a proportionately smaller amount of fluids, because many clinicians dose crystalloids per lean body mass instead of actual body weight. The ASEPSIS scores in this trial are low compared with other trials. In a study of normothermia and SSI, 3 scores were 7 and 13 in the normothermic and hypothermic groups, respectively, and in the Greif and colleagues 2 study, they were 3 and 5 in the 30 and 80% oxygen groups, respectively. Our low ASEPSIS scores were not accompanied by a reduction in overall SSI. The explanation for this is not immediately apparent. There were no major differences in how data were collected. Whether changes in care are now leading to changes in ASEPSIS scores that are not reflected in reduced SSI is unclear. Perhaps the increased prevalence in obesity observed in this study compared with previous studies of SSI is a contributory factor. Moreover, ASA classification and SENIC scores were not predictive of SSI, but the study was not powered for this endpoint. However, we believe that the power of this study to detect a meaningful reduction in SSI by either oxygen or dexamethasone was adequate.
Smoking also independently increased the risk of SSI, which is unsurprising given that it worsens pulmonary mechanics, increases closing capacity, and causes chronic obstructive lung disease. Smoking decreases tissue oxygen and impairs immune function and collagen production, each of which might contribute to infection risk. This appears to be mediated by slow-toresolve effects on neutrophils. In addition, it appears that smoking acutely impairs wound healing. 43 After discharge, subjects were followed with standardised phone interviews and were asked to return to their physician or hospital if their answers suggested they had an infection. Although post-discharge SSI was uncommon, partial reliance on phone interviews for a major study outcome was a limitation of our trial. Because the timing of post-discharge assessment visits is dependent on the specific procedure and the operating surgeons' practices, it was not feasible to do the 30 day followup assessment in person.
Corticosteroids impair innate immune responses and might impair healing. Chronic preoperative corticosteroid use increases wound infection risk. 25 26 But until recently, no randomized trials specifically evaluated the effect of single-dose corticosteroids on SSI and wound healing. Recently two retrospective analyses 29 32 and two case-control studies 24 31 assessed the effect of smalldose dexamethasone on surgical wound complications. Three of these studies showed no association between PONV doses of dexamethasone and surgical wound complications. Our results strongly suggest that administration of low-dose dexamethasone for prevention of PONV should not be avoided for fear of promoting wound infections. Although we observed a range of SSIs, we elected not to compare the incidence among participating centres since in some centres the number of infections identified was too low to make such comparisons meaningful.
We conducted an intention to treat analysis, meaning that subjects were analysed as if they had received F O 2 =0.8, even if their actual F O 2 was much lower. This could have obscured differences in SSI between groups and tends to decrease the power of the study. This issue was exacerbated by the relatively large number of patients (n=31) lost to follow-up. Nonetheless, even if all of these subjects had been retained, it is unlikely that this would have altered the overall negative findings significantly.
In summary, our data suggest that supplemental oxygen does not reduce wound infection risk. Our results conflict with prior randomized trials, but are consistent with more recent ones. Our results also suggest that 4 mg of intraoperative dexamethasone does not increase wound infection risk.
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